Literature DB >> 24712925

Reduced expression of TLR3, TLR10 and TREM1 by human macrophages in Chronic cavitary pulmonary aspergillosis, and novel associations of VEGFA, DENND1B and PLAT.

N L D Smith1, J Hankinson, A Simpson, D W Denning, P Bowyer.   

Abstract

Chronic cavitary pulmonary aspergillosis (CCPA) is an uncommon but serious pulmonary disease of humans, with an annual mortality rate of 10-30%. It is caused by the fungus Aspergillus fumigatus. Patients are overtly immunocompetent; however, some immunogenetic defect is likely. To investigate this, we performed a genetic association study analysing biologically plausible candidate genes in 112 CCPA patients and 279 healthy controls, and investigated gene expression in monocyte-derived macrophages from patients and controls at baseline and during stimulation with A. fumigatus. Single-nucleotide polymorphisms (SNPs) associated with CCPA were found in TLR1, CLEC7A (dectin-1), PLAT (n=2), VEGFA, and DENND1B. Macrophages from CCPA patients showed low TLR3 and TLR10 expression and high TREM1 expression at baseline, as compared with macrophages from healthy subjects, with major expression differences being seen in most Toll-like receptors (TLRs) during 9 h of co-culture with A. fumigatus. The differences in baseline expression between the healthy and CCPA groups suggest roles for TLR3 and TLR10 in susceptibility to CCPA, and the association of SNPs in PLAT (n=2), VEGFA and DENND1B supports novel roles for plasminogen activation and angiogenesis and of these genes specifically in susceptibility to CCPA.
© 2014 The Authors Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Aspergilloma; Aspergillus fumigatus; CCPA; TLR; aspergillosis; gene expression; genetic susceptibility; immune response; monocyte-derived macrophages

Mesh:

Substances:

Year:  2014        PMID: 24712925     DOI: 10.1111/1469-0691.12643

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  10 in total

Review 1.  Innate Lung Defense during Invasive Aspergillosis: New Mechanisms.

Authors:  Jaleesa M Garth; Chad Steele
Journal:  J Innate Immun       Date:  2017-02-24       Impact factor: 7.349

2.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

3.  Genetic susceptibility to allergic bronchopulmonary aspergillosis in asthma: a genetic association study.

Authors:  Nicola L D Overton; David W Denning; Paul Bowyer; Angela Simpson
Journal:  Allergy Asthma Clin Immunol       Date:  2016-09-27       Impact factor: 3.406

4.  TREM1 regulates antifungal immune responses in invasive pulmonary aspergillosis.

Authors:  L Bernal-Martínez; S M Gonçalves; B de Andres; C Cunha; I Gonzalez Jimenez; K Lagrou; E Mellado; M L Gaspar; J A Maertens; A Carvalho; L Alcazar-Fuoli
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 5.  Cytokine Profile of Invasive Pulmonary Aspergillosis in Severe COVID-19 and Possible Therapeutic Targets.

Authors:  Alessandro Russo; Helen Linda Morrone; Salvatore Rotundo; Enrico Maria Trecarichi; Carlo Torti
Journal:  Diagnostics (Basel)       Date:  2022-06-01

6.  A prospective longitudinal study of chronic pulmonary aspergillosis in pulmonary tuberculosis in Indonesia (APICAL).

Authors:  Findra Setianingrum; Anna Rozaliyani; Robiatul Adawiyah; Ridhawati Syam; Mulyati Tugiran; Cut Yulia Indah Sari; Finny Nandipinto; Johannes Ramnath; Arief Riadi Arifin; Diah Handayani; Erlina Burhan; Martin Rumende; Retno Wahyuningsih; Riina Rautemaa-Richardson; David W Denning
Journal:  Thorax       Date:  2021-11-30       Impact factor: 9.102

7.  Innate and Adaptive Immune Defects in Chronic Pulmonary Aspergillosis.

Authors:  Felix Bongomin; Chris Harris; Philip Foden; Chris Kosmidis; David W Denning
Journal:  J Fungi (Basel)       Date:  2017-05-29

Review 8.  Chronic Pulmonary Aspergillosis-Where Are We? and Where Are We Going?

Authors:  Gemma E Hayes; Lilyann Novak-Frazer
Journal:  J Fungi (Basel)       Date:  2016-06-07

9.  Mutations in EEA1 are associated with allergic bronchopulmonary aspergillosis and affect phagocytosis of Aspergillus fumigatus by human macrophages.

Authors:  Nicola L D Overton; Axel A Brakhage; Andreas Thywißen; David W Denning; Paul Bowyer
Journal:  PLoS One       Date:  2018-03-16       Impact factor: 3.240

Review 10.  Advances in Understanding Human Genetic Variations That Influence Innate Immunity to Fungi.

Authors:  Richard M Merkhofer; Bruce S Klein
Journal:  Front Cell Infect Microbiol       Date:  2020-02-28       Impact factor: 6.073

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.